K. Martijn Akkerhuis
Papers
1
Total Citations
157
H-Index
1
About
K. Martijn Akkerhuis is a leading cardiovascular researcher whose work bridges lipidomics and clinical cardiology to improve risk prediction in coronary artery disease (CAD). His major contributions center on identifying and validating molecular lipid species as powerful biomarkers for adverse outcomes. In his landmark 2018 study, cited over 150 times, Akkerhuis demonstrated that specific plasma lipid profiles—including ten high-risk molecular lipid species and three ceramide ratios—can predict major adverse cardiac events (MACEs) over a median follow-up of nearly five years in CAD patients. This work has profound implications for personalized medicine, enabling clinicians to stratify risk beyond traditional factors. By integrating advanced lipidomics with long-term clinical data from a cohort of 581 patients, Akkerhuis has helped shift the paradigm toward more precise, molecular-based prognostication. His research continues to influence how we understand lipid-driven mechanisms in atherosclerosis and has opened new avenues for targeted therapeutic interventions. For students and researchers, Akkerhuis exemplifies how cutting-edge molecular profiling can translate into tangible improvements in patient care.
Research Focus
Key Achievements
Top Papers
- 1